Research Institute for Pesticides and Water, University Jaume I, Avda. Sos Baynat, E-12071 Castellón, Spain.
Chemosphere. 2012 Apr;87(5):453-62. doi: 10.1016/j.chemosphere.2011.12.025. Epub 2012 Jan 4.
A survey on the presence of pharmaceuticals in urban wastewater of a Spanish Mediterranean area (Castellon province) was carried out. The scope of the study included a wide variety of pharmaceuticals belonging to different therapeutical classes. For this purpose, 112 samples, including influent and effluent wastewater, from different conventional wastewater treatment plants were collected. Two monitoring programmes were carried out along several seasons. The first was in June 2008 and January 2009, and the second in April and October 2009. During the first monitoring, the occurrence of 20 analytes in 84 urban wastewater samples (influent and effluent) was studied. The selection of these pharmaceuticals was mainly based on consumption. From these, 17 compounds were detected in the samples, with analgesics and anti-inflammatories, cholesterol lowering statin drugs and lipid regulators being the most frequently detected groups. 4-Aminoantipyrine, bezafibrate, diclofenac, gemfibrozil, ketoprofen, naproxen and venlafaxine were the compounds most frequently found. In the highlight of these results, the number of analytes was increased up to around 50. A lot of antibiotic compounds were added to the target list as they were considered "priority pharmaceuticals" due to their more potential hazardous effects in the aquatic environment. Data obtained during the second monitoring programme (spring and autumn) corroborated the results from the first one (summer and winter). Analgesics and anti-inflammatories, lipid regulators together with quinolone and macrolide antibiotics were the most abundant pharmaceuticals. Similar median concentrations were found over the year and seasonal variation was not clearly observed. The removal efficiency of pharmaceuticals in the wastewater treatment plants was roughly evaluated. Our results indicated that elimination of most of the selected compounds occurred during the treatment process of influent wastewater, although it was incomplete.
对西班牙地中海地区(卡斯特利翁省)城市废水中药物的存在进行了调查。研究范围包括属于不同治疗类别的各种药物。为此,收集了来自不同常规污水处理厂的 112 个进水和出水废水样本。进行了两个监测计划,跨越了多个季节。第一个是在 2008 年 6 月和 2009 年 1 月,第二个是在 2009 年 4 月和 10 月。在第一次监测中,研究了 84 个城市废水样本(进水和出水)中 20 种分析物的存在。这些药物的选择主要基于消费。在这些药物中,在样本中检测到 17 种化合物,其中镇痛药和消炎药、降胆固醇他汀类药物和脂质调节剂是最常检测到的组。4-氨基安替比林、贝扎贝特、双氯芬酸、吉非贝齐、酮洛芬、萘普生和文拉法辛是最常发现的化合物。在这些结果中,分析物的数量增加到了大约 50 个左右。由于抗生素化合物在水生环境中具有更大的潜在危害效应,因此将许多抗生素化合物添加到目标列表中,被视为“优先药物”。在第二次监测计划(春季和秋季)中获得的数据证实了第一个监测计划(夏季和冬季)的结果。镇痛药和消炎药、脂质调节剂以及喹诺酮类和大环内酯类抗生素是最丰富的药物。全年发现的中位数浓度相似,季节变化不明显。污水处理厂中药物的去除效率大致进行了评估。我们的结果表明,在处理进水废水的过程中,大多数选定化合物的消除发生了,尽管不完全。